Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v22-FR | Version v7-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2024-03-28 | 2023-07-21 |
| Drug Identification Number | 02244475 | 02244475 |
| Brand name | DIPYRIDAMOLE INJECTION, USP | DIPYRIDAMOLE INJECTION, USP |
| Common or Proper name | DIPYRIDAMOLE INJECTION, USP | DIPYRIDAMOLE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | DIPYRIDAMOLE | DIPYRIDAMOLE |
| Strength(s) | 5MG | 5MG |
| Dosage form(s) | LIQUID | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 mL | 10 mL |
| ATC code | B01AC | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-07-01 | 2023-07-01 |
| Actual start date | 2023-08-23 | 2023-07-01 |
| Estimated end date | 2024-06-30 | 2023-09-08 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | Yes | Yes |
| Company comments | Please be advised that this product is on 100% allocation. | Fresenius Kabi Canada regrets to advise that due to a delay in product release, we will be extending the backorder on our Dipyridamole Injection, USP 5 mg/mL SD Vial 10 mL until September 8, 2023. We are working diligently with our plant to expedite availability and mitigate this shortage. |
| Health Canada comments |